Insider Title Company Date Price Return Shares Value
Foehr Matthew W President and CEO OmniAb, Inc. (OABI) 2024-05-24 $4.42 -6.9% 240,000 $1,059,840
Foehr Matthew W President and CEO OmniAb, Inc. (OABI) 2024-03-22 $5.19 -20.8% 225,000 $1,167,750
Foehr Matthew W Chief Executive Officer OmniAb, Inc. (OABI) 2023-12-12 $5.05 -18.6% 200,000 $1,010,000
Foehr Matthew W President and CEO OmniAb, Inc. (OABI) 2023-11-10 $4.27 -3.7% 95,000 $405,517
Foehr Matthew W President and CEO OmniAb, Inc. (OABI) 2023-08-14 $5.48 -25.0% 45,000 $246,600
Foehr Matthew W Chief Executive Officer OmniAb, Inc. (OABI) 2023-06-09 $4.52 -9.1% 115,000 $519,800
Foehr Matthew W Chief Executive Officer OmniAb, Inc. (OABI) 2023-05-12 $3.40 20.9% 440,000 $1,496,000
Foehr Matthew W President OmniAb, Inc. (OABI) 2022-12-12 $3.77 9.2% 150,000 $564,765
Foehr Matthew W President OmniAb, Inc. (OABI) 2022-11-30 $3.39 21.3% 300,000 $1,016,340
Foehr Matthew W President OmniAb, Inc. (OABI) 2022-11-09 $2.76 48.8% 100,000 $276,160
Foehr Matthew W President and COO LIGAND PHARMACEUTICALS INC (LGND) 2022-05-13 $82.76 24.6% 2,500 $206,910
Foehr Matthew W Non-Executive Director Viking Therapeutics, Inc. (VKTX) 2022-05-02 $2.47 2141.6% 45,000 $111,195
Foehr Matthew W Non-Executive Director Viking Therapeutics, Inc. (VKTX) 2021-06-10 $5.69 873.5% 20,000 $113,800
Return Profit / (loss) Cost
Total 42.9% $3,513,648 $8,194,677